In further support of TGF-β driving tumour progression, high levels of TGF-β1 ligand are expressed at regions of invasion and metastasis in clinical breast tumour specimens [18,19], and mRNA expression of a TGF-β response signature in patients is associated with increased incidence of breast cancer metastasis [16]. Here, TGFB1 is linked to breast cancer.